Army veteran Allen Gent, 76, has commended Newmedica’s Darlington clinic after successful cataract surgery restored his ...

Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from ...

Glaucoma is a common eye condition that can affect people as they age, especially those over 60. It damages the optic nerve, ...

The agreement outlines how independent sector capacity could help to address waiting lists. OT asked providers of ...

The American Glaucoma Society and American Academy of Ophthalmology are warning eye doctors to be aware of potentially toxic ...

Optegra has launched a new NHS service to support glaucoma patients in Greater Manchester. The service at Optegra Eye ...

Glaukos GKOS recently announced positive data from a new 36-month follow-up analysis of its two Phase 3 pivotal clinical ...

Dr. Frenkel highlights a comprehensive program that covers the latest breakthroughs in glaucoma and cataract surgery to in-depth discussions on AI, retinal treatments, and new drug-delivery platforms, ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ...

The Company’s fourth quarter and full year 2024 financial results are preliminary and subject to the completion of the Company’s 2024 audit. The Company expects to announce complete fourth quarter and ...

Optegra Eye Hospital Manchester, located in Didsbury, has launched a new NHS glaucoma treatment pathway aimed at reducing ...